12511232

Source:http://linkedlifedata.com/resource/pubmed/id/12511232

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0022646, umls-concept:C0034693, umls-concept:C0221198, umls-concept:C0288171, umls-concept:C0441712, umls-concept:C1708528
pubmed:issue	1
pubmed:dateCreated	2003-1-3
pubmed:abstractText	To investigate the mechanisms of angiotensin II receptor antagonist irbesartan (Irb) in prevention of renal lesion in streptozotocin (STZ)-induced diabetic rats.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100956087
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin Receptor Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Biphenyl Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Connective Tissue Growth Factor, http://linkedlifedata.com/resource/pubmed/chemical/Ctgf protein, rat, http://linkedlifedata.com/resource/pubmed/chemical/Immediate-Early Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Intercellular Signaling Peptides..., http://linkedlifedata.com/resource/pubmed/chemical/Tetrazoles, http://linkedlifedata.com/resource/pubmed/chemical/Tgfb1 protein, rat, http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta, http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta1, http://linkedlifedata.com/resource/pubmed/chemical/irbesartan
pubmed:status	MEDLINE
pubmed:month	Jan
pubmed:issn	1671-4083
pubmed:author	pubmed-author:CiukJJ, pubmed-author:LiuBi-ChengBC, pubmed-author:LiuNai-FengNF, pubmed-author:LuoDong-DongDD, pubmed-author:PhillipsA OAO, pubmed-author:RuanXiong-ZhongXZ, pubmed-author:SunJingJ
pubmed:issnType	Print
pubmed:volume	24
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	67-73
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:12511232-Angiotensin Receptor Antagonists, pubmed-meshheading:12511232-Animals, pubmed-meshheading:12511232-Antihypertensive Agents, pubmed-meshheading:12511232-Biphenyl Compounds, pubmed-meshheading:12511232-Connective Tissue Growth Factor, pubmed-meshheading:12511232-Diabetes Mellitus, Experimental, pubmed-meshheading:12511232-Diabetic Nephropathies, pubmed-meshheading:12511232-Immediate-Early Proteins, pubmed-meshheading:12511232-Intercellular Signaling Peptides and Proteins, pubmed-meshheading:12511232-Male, pubmed-meshheading:12511232-Random Allocation, pubmed-meshheading:12511232-Rats, pubmed-meshheading:12511232-Rats, Sprague-Dawley, pubmed-meshheading:12511232-Tetrazoles, pubmed-meshheading:12511232-Transforming Growth Factor beta, pubmed-meshheading:12511232-Transforming Growth Factor beta1
pubmed:year	2003
pubmed:articleTitle	Mechanisms of irbesartan in prevention of renal lesion in streptozotocin-induced diabetic rats.
pubmed:affiliation	Department of Pathophysiology, Nanjing Medical University, Nanjing 210002, China. kidney@jlonline.com
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't